Z-0205-2026Class II
Product: STA Liatest D-Di; REF: 00515
Diagnostica Stago, Inc. / initiated 2025-09-12 / Open, Classified
Diagnostica Stago, Inc. began a recall of Product: STA Liatest D-Di; REF: 00515 on . FDA classified it as Class II and gives the reason as "A potential risk of underestimation of D-Dimer (D-Di) levels with the two listed lots". As of , the recall status on record is Open, Classified.
Recall record
- Recall number
- Z-0205-2026
- Classification
- Class II
- Status
- Open, Classified
- Initiated
- Posted
- Recalling firm
- Diagnostica Stago, Inc.
- Product
- Product: STA Liatest D-Di; REF: 00515;
- Product code
- DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control
- Reason for recall
- A potential risk of underestimation of D-Dimer (D-Di) levels with the two listed lots.
- FDA root cause
- Under Investigation by firm
- Action
- On September 12, 2025 URGENT: MEDICAL DEVICE RECALL (REMOVAL) letters were emailed to customers. Actions for customers: Discontinue use of affected lots and dispose of them in accordance with your local regulations. Complete and return response form. For additional information, please contact Stago's 24/7 Hotline at 1-800-725-0607.
- Quantity in commerce
- 12740 units
- Distribution
- Worldwide distribution- US Nationwide and the country of Canada.
- Product codes and lots
- REF: 00515; UDI-DI: 03607450005158; Lot numbers: 271382, 271411; Expiration 09/30/2025;
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-0205-2026 | Class II | Ongoing | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
